Candel Therapeutics Financials
| CADL Stock | USD 7.75 3.14 68.11% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.46 | 2.5943 |
|
|
Investors should never underestimate Candel Therapeutics' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Candel Therapeutics' cash flow, debt, and profitability to make informed and accurate decisions about investing in Candel Therapeutics.
Net Income |
|
Candel | Select Account or Indicator |
Understanding current and past Candel Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Candel Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Candel Therapeutics' assets may result in an increase in income on the income statement.
Candel Therapeutics Stock Summary
Candel Therapeutics competes with Aerovate Therapeutics, Adagene, Acrivon Therapeutics,, Rezolute, and AN2 Therapeutics. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company was incorporated in 2003 and is based in Needham, Massachusetts. Candel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US1374041093 |
| CUSIP | 137404109 |
| Location | Massachusetts; U.S.A |
| Business Address | 117 Kendrick Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.candeltx.com |
| Phone | 617 916 5445 |
| Currency | USD - US Dollar |
Candel Therapeutics Key Financial Ratios
| Return On Equity | -4.81 | ||||
| Price To Sales | 436.42 X | ||||
| Revenue | 31 K | ||||
| Gross Profit | (20.66 M) | ||||
| EBITDA | (37.43 M) |
Candel Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Candel Therapeutics's current stock value. Our valuation model uses many indicators to compare Candel Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Candel Therapeutics competition to find correlations between indicators driving Candel Therapeutics's intrinsic value. More Info.Candel Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Candel Therapeutics' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Candel Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Candel Therapeutics Systematic Risk
Candel Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Candel Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Candel Therapeutics correlated with the market. If Beta is less than 0 Candel Therapeutics generally moves in the opposite direction as compared to the market. If Candel Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Candel Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Candel Therapeutics is generally in the same direction as the market. If Beta > 1 Candel Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Candel Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Candel Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Candel Therapeutics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Candel Therapeutics December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Candel Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Candel Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Candel Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Candel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Candel Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 26.59 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.14 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Revenue Per Share 0.001 | Return On Assets (0.52) | Return On Equity (4.81) |
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.